Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Antiphospholipid-related chorea.

Peluso S, Antenora A, De Rosa A, Roca A, Maddaluno G, Brescia Morra V, De Michele G.

Front Neurol. 2012 Oct 22;3:150. doi: 10.3389/fneur.2012.00150. eCollection 2012.

2.

The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.

Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.

J Rheumatol. 2001 Dec;28(12):2637-43.

PMID:
11764209
4.

[Antiphospholipid syndrome and stroke].

Kitagawa Y.

Rinsho Shinkeigaku. 2005 Nov;45(11):852-5. Japanese.

PMID:
16447744
5.

[Neurological aspects in antiphospholipid syndrome].

Kitagawa Y.

Rinsho Shinkeigaku. 2003 Nov;43(11):744-7. Review. Japanese.

PMID:
15152454
6.
7.

Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome.

Breen KA, Seed P, Parmar K, Moore GW, Stuart-Smith SE, Hunt BJ.

Thromb Haemost. 2012 Mar;107(3):423-9. doi: 10.1160/TH11-08-0554. Epub 2012 Jan 11.

PMID:
22234447
8.

Antiphospholipid antibody-associated chorea.

Orzechowski NM, Wolanskyj AP, Ahlskog JE, Kumar N, Moder KG.

J Rheumatol. 2008 Nov;35(11):2165-70. Epub 2008 Oct 15.

PMID:
18925689
9.

Identification of thrombin antibodies in patients with antiphospholipid syndrome.

Miesbach W, Matthias T, Scharrer I.

Ann N Y Acad Sci. 2005 Jun;1050:250-6.

PMID:
16014540
11.

Neurological manifestations of antiphospholipid antibody syndrome.

Brey RL, Escalante A.

Lupus. 1998;7 Suppl 2:S67-74. Review.

PMID:
9814677
12.
13.

Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events.

Otomo K, Atsumi T, Amengual O, Fujieda Y, Kato M, Oku K, Horita T, Yasuda S, Koike T.

Arthritis Rheum. 2012 Feb;64(2):504-12. doi: 10.1002/art.33340.

14.

Antiphospholipid antibody profiles and their clinical associations in Chinese patients with systemic lupus erythematosus.

Mok MY, Chan EY, Fong DY, Leung KF, Wong WS, Lau CS.

J Rheumatol. 2005 Apr;32(4):622-8.

PMID:
15801016
15.

The geoepidemiology of the antiphospholipid antibody syndrome.

Biggioggero M, Meroni PL.

Autoimmun Rev. 2010 Mar;9(5):A299-304. doi: 10.1016/j.autrev.2009.11.013. Epub 2009 Nov 25. Review.

PMID:
19932199
16.

[Ischemic stroke with antiphospholipid antibody].

Kitagawa Y, Ohkuma H, Tokuoka K.

Brain Nerve. 2008 Oct;60(10):1144-58. Review. Japanese.

PMID:
18975602
17.

Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.

Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM.

Arthritis Rheum. 2004 Aug;50(8):2569-79.

18.

Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome?

Ghirardello A, Doria A, Ruffatti A, Rigoli AM, Vesco P, Calligaro A, Gambari PF.

Ann Rheum Dis. 1994 Feb;53(2):140-2.

19.

Antiphospholipid antibodies: evaluation of the thrombotic risk.

Devreese KM.

Thromb Res. 2012 Oct;130 Suppl 1:S37-40. doi: 10.1016/j.thromres.2012.08.270. Review.

PMID:
23026657
20.

European attempts for the standardisation of the antiphospholipid antibodies.

Tincani A, Filippini M, Scarsi M, Galli M, Meroni PL.

Lupus. 2009 Sep;18(10):913-9. doi: 10.1177/0961203309106919.

PMID:
19671792

Supplemental Content

Support Center